PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 1/21

Target Met

PharmD_KS's avatar
PharmD_KS
Jan 20, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The 2026 Equity Markets Year Ahead can be watched here: 2026 Equity Markets Year Ahead

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 1/18

After planning for SPX 6980 and NQ 26015.5 as a major area of resistance for 2+ months, both areas were hit last week. The initial dip on Wednesday was bought, but a second test and failure on Thursday left me quite bearish. I was looking for a retest of Wednesday’s low “by Tuesday.”

Friday then looked like clear re-distribution, on NQ in particular

This was after the the warning on Tuesday ahead of Wednesday’s sell:

I was accumulating a “bear savings account” which means taking profit from day trades and buying puts (a directional short on top of hedges). The bear savings account paid nicely today.

From the weekly plan, we were looking for a move to 6817.5-6821 below ES 6908.5-6911:

That entire move played out today, and that major sequence is effectively complete:

This was my short term target, and profits on shorts were taken accordingly. The question now is whether we see direct continuation lower, if that was a durable swing low for new highs, or if a lower high is likely to be made.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture